Overview

myTomorrows connects patients with serious diseases to BioPharma companies developing new treatments through a platform that coordinates patient recruitment for clinical trials, expanded access programs, and Real World data collection. The product links patients, healthcare professionals, and pharma teams in one hub where eligibility screening, access requests, and trial enrollment are managed, and real-world data is gathered to support programs. Revenue comes from partnerships with BioPharma companies that pay for these services, helping them recruit patients faster and collect insights from real-world treatment use. The company aims to shorten the time to bring new therapies to patients by making it easier to find eligible participants, manage access options, and gather real-world evidence.